Clinical Trial Update: A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS) [Phase 2]

View source ↗

Summary

This entry provides a trial update for a Phase 2 study of the investigational drug 608 in Ankylosing Spondylitis. The current status of the study is not disclos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• 608

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN